Meng-Fen Wu
Impact in
- Oncology top 0.2%
- CAR-T cell therapy research
- Viral-associated cancers and disorders
- Immunology top 1%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
Papers in
- Oncology 38
- CAR-T cell therapy research 19
- Pancreatic and Hepatic Oncology Research 4
-
- Hedgehog Signaling Pathway Studies 4
- Co-authors
- Hao Liu (14 shared papers)Helen E. Heslop (19 shared papers)Malcolm K. Brenner (14 shared papers)Cliona M. Rooney (10 shared papers)Gianpietro Dotti (8 shared papers)Susan G. Hilsenbeck (19 shared papers)Stephen Gottschalk (10 shared papers)Adrian P. Gee (8 shared papers)
- Journals
- Blood (8 papers)Journal of Clinical Oncology (5 papers)Breast Cancer Research and Treatment (4 papers)Clinical Cancer Research (4 papers)Molecular Therapy (3 papers)
- Partner nations
- United StatesGermanyChina
In The Last Decade
Meng-Fen Wu
62 papers receiving 5.6k citations
Meng-Fen Wu's Hit Papers
Peers
Comparison fields: 5 of 100
- Oncology 4.1k
- Immunology 1.5k
- Genetics 1.2k
- Genetics 302
- Hematology 287
Countries citing papers authored by Meng-Fen Wu
This map shows the geographic impact of Meng-Fen Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meng-Fen Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meng-Fen Wu more than expected).
Fields of papers citing papers by Meng-Fen Wu
This network shows the impact of papers produced by Meng-Fen Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meng-Fen Wu. The network helps show where Meng-Fen Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Meng-Fen Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Antitumor activity and long-term fate of chimeric antigen receptor–positive T cells in patients with neuroblastoma Hit paper breakdown → | 2011 | 893 |
| 2 | Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients Hit paper breakdown → | 2009 | 591 |
| 3 | 2017 | 349 | |
| 4 | 2017 | 287 | |
| 5 | 2013 | 282 | |
| 6 | 2017 | 262 | |
| 7 | 2016 | 237 | |
| 8 | 2012 | 198 | |
| 9 | 2010 | 193 | |
| 10 | 2010 | 162 | |
| 11 | 2007 | 148 | |
| 12 | 2014 | 148 | |
| 13 | 2018 | 146 | |
| 14 | 2014 | 139 | |
| 15 | 2017 | 134 | |
| 16 | 2011 | 133 | |
| 17 | 2018 | 99 | |
| 18 | 2008 | 94 | |
| 19 | 2015 | 69 | |
| 20 | 2008 | 66 |
About Meng-Fen Wu
Meng-Fen Wu is a scholar working on Oncology, Molecular Biology, Genetics, Immunology and Hematology, having authored 62 papers that have together received 5.7k indexed citations. Recurring topics across this work include CAR-T cell therapy research (19 papers), Virus-based gene therapy research (7 papers), Hematopoietic Stem Cell Transplantation (5 papers), Neuroblastoma Research and Treatments (4 papers), Hedgehog Signaling Pathway Studies (4 papers), Immune Cell Function and Interaction (4 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). The work is most often cited by research in Oncology (4.1k citations), Immunology (1.5k citations), Genetics (1.2k citations), Genetics (302 citations) and Hematology (287 citations). Meng-Fen Wu has collaborated with scholars based in United States, Germany and China. Frequent co-authors include Hao Liu, Helen E. Heslop, Malcolm K. Brenner, Cliona M. Rooney, Gianpietro Dotti, Susan G. Hilsenbeck, Stephen Gottschalk, Adrian P. Gee, Barbara Savoldo and Martin Pulé. Their work appears in journals such as Blood, Journal of Clinical Oncology, Breast Cancer Research and Treatment, Clinical Cancer Research and Molecular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.